Tetherex Pharmaceuticals Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 8

Tetherex Pharmaceuticals General Information

Description

Developer of medicinal drugs designed to treat thrombosis, inflammation and tumor metastasis. The company's drugs develop novel first-in-class therapeutics targeting cell adhesion proteins in thrombotic, inflammatory and oncologic diseases to work on the molecular mechanisms of cell adhesion and inflammation, enabling patients who suffer these afflictions to enjoy decent and long lives.

Contact Information

Website
www.tetherex.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 840 Research Parkway
  • Suite 516
  • Oklahoma City, OK 73104
  • United States
+1 (405)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 840 Research Parkway
  • Suite 516
  • Oklahoma City, OK 73104
  • United States
+1 (405)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tetherex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private Completed Clinical Trials - General
6. Later Stage VC (Series B) 06-Mar-2018 Completed Clinical Trials - General
5. Later Stage VC (Series A) 09-Feb-2015 Completed Clinical Trials - General
4. Later Stage VC (Series A) 17-Sep-2012 Completed Clinical Trials - General
3. Angel (individual) 01-Apr-2010 Completed Clinical Trials - General
2. Grant 16-Jun-2009 $3.2M Completed Clinical Trials - General
1. Grant 28-Apr-2009 $300K Completed Clinical Trials - General
To view Tetherex Pharmaceuticals’s complete valuation and funding history, request access »

Tetherex Pharmaceuticals Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view Tetherex Pharmaceuticals’s complete cap table history, request access »

Tetherex Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medicinal drugs designed to treat thrombosis, inflammation and tumor metastasis. The company's drugs develo
Drug Discovery
Oklahoma City, OK

Plymouth Meeting, PA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tetherex Pharmaceuticals Competitors (100)

One of Tetherex Pharmaceuticals’s 100 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Neurona Therapeutics Formerly VC-backed South San Francisco, CA
Zura Bio Formerly VC-backed Henderson, NV
Centrose Venture Capital-Backed Madison, WI
Gangagen Biotechnologies Venture Capital-Backed Bangalore, India
You’re viewing 5 of 100 competitors. Get the full list »

Tetherex Pharmaceuticals Patents

  • 20

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Tetherex Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202408901-D0 Antibodies and methods of treatment Inactive 20-Jun-2024
GB-202408900-D0 Methods of treatment and medical uses Inactive 20-Jun-2024
GB-202408903-D0 Pharmaceutical compositions and medical uses Inactive 20-Jun-2024
WO-2025191536-A1 Antibodies and methods of treatment Pending 14-Mar-2024
AU-2025237481-A1 Pharmaceutical compositions and methods of treatment Pending 14-Mar-2024 A61K9/0019
To view Tetherex Pharmaceuticals’s complete patent history, request access »

Tetherex Pharmaceuticals Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mayo Clinic Ventures Corporate Venture Capital Minority
Angel (individual) Minority
i2E Accelerator/Incubator Minority
MPM BioImpact Venture Capital Minority
Oklahoma Life Science Fund Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Tetherex Pharmaceuticals FAQs

  • When was Tetherex Pharmaceuticals founded?

    Tetherex Pharmaceuticals was founded in 2002.

  • Where is Tetherex Pharmaceuticals headquartered?

    Tetherex Pharmaceuticals is headquartered in Oklahoma City, OK.

  • What industry is Tetherex Pharmaceuticals in?

    Tetherex Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Tetherex Pharmaceuticals a private or public company?

    Tetherex Pharmaceuticals is a Private company.

  • What is Tetherex Pharmaceuticals’s current revenue?

    The current revenue for Tetherex Pharmaceuticals is .

  • How much funding has Tetherex Pharmaceuticals raised over time?

    Tetherex Pharmaceuticals has raised $83.8M.

  • Who are Tetherex Pharmaceuticals’s investors?

    Mayo Clinic Ventures, , i2E, MPM BioImpact, and Oklahoma Life Science Fund are 5 of 8 investors who have invested in Tetherex Pharmaceuticals.

  • Who are Tetherex Pharmaceuticals’s competitors?

    Inovio Pharmaceuticals, Neurona Therapeutics, Zura Bio, Centrose, and Gangagen Biotechnologies are some of the 100 competitors of Tetherex Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process